text_combined: 9 buy stock tttp tttp tttp tttp tttp stock finder newsletter wants inform aggressive investors company feel extremely undervalued poised growth 12 20 plus inc otcbb tttp fiscal year end dec 3152 week high 25 shares outstanding 30 millionshares public float 4 million target price next 3 5 days 0 75 0 80 target price next 10 days 0 92 company 12 20 plus inc otcbb tttp late stage development company produces markets neurochemical research group division highly effective condition specific supplements often referred neutraceuticals products manufactured fda approved labs contain sophisticated combination extensively researched nutritional elements contain herbs retail sales explosive dietary supplement market expected hit 40 billion year 2007 according frost sullivan reports marketing research product development beta testing various mergers acquisitions 2003 positioned 12 20 plus tttp roll full product line consisting 7 products proprietary formula multi billion dollar counter otc market 12 20 plus ready capitalize exceptional product line key facts 12 20 plus inc introduced 9 products market company owns proprietary rights products produced fda approved labs one products anaplex antidepressant currently sold anddistributed longs drug stores one america leading drug stores 400 stores company negotiating deals two major distributors europe healthcare products currently process attempting market one newest products revolutionary hydration product u military allied forces overseas industry neutraceutical sector experienced great growth past five years capped 2002 revenues global nutrition markets hit 160 billion united states took responsibility 1 3 56 5 billion 18 5 coming nutrition markets 19 8 functional foods 4 4 billion personal care products safe say globally looking new ways live healthier longer lives pharmaceutical remedies could quickly thing past estimated 95 medical doctors practices entail writing pharmaceutical prescriptions 50 prescriptions treat side effects medications utilized treat specific ailment people longer neglecting facts putting bodies may good medicinal foods nutritionally high powered foods natural products industry long time emerging scientific research public interest reached mainstream seems though everywhere look days talk dieting whether low carbohydrate high protein atkins diet zone diet millions options world concerned weight according american obesity association adults age 20 united states 127 million overweight 60 million obese 9 million severely obese obesity increases risk illness 30 serious medical conditions fact forcing many snack food soft drink companies come new healthier products meet taste standards today consumers comparable companies sector usana health sciences inc nasdaq usna current price 27 39 nutraceutical international corp nasdaq nutr current price 25 97 vital living inc otcbb vtlv current price 68 dis claimer contains forward lo 0 king statements within meaning private securities litigation reform act 1995 statements may identified terms expect believe may explode move undervalued intend similar terms information statement could 100 accurate newsletter responsible registered investment advisor broker dealer offer buy sell securities recommendation securities companies profiled purchased sold held individuals entities learn profiled companies newsletter paid 3000 cash third party publish report investing companies profiled high risk use information reading purposes anyone decides act investor investor sole risk investors advised invest without proper advertisement attorney registered financial broker rely solely information presented additional independent research form opinion decision regarding investing profiled companies advised purchase high risk securities may result loss entire investment void prohibited owners publication partners may already free trading shares tttp may immediately sell time date stated subject change without notice